Paternal obesity modifies the effect of an antenatal lifestyle intervention in women who are overweight or obese on newborn anthropometry by Dodd, Jodie M et al.
1Scientific RepoRts | 7: 1557  | DOI:10.1038/s41598-017-01672-w
www.nature.com/scientificreports
Paternal obesity modifies the 
effect of an antenatal lifestyle 
intervention in women who are 
overweight or obese on newborn 
anthropometry
Jodie M. Dodd  1,2, Lodewyk E. Du Plessis1, Andrea R. Deussen  1, Rosalie M. Grivell1,6, Lisa 
N. Yelland1,3,4, Jennie Louise1,4, Andrew J. Mcphee5, Jeffrey S. Robinson1 & Julie A. Owens1
The contribution of paternal obesity to pregnancy outcomes has been little described. Our aims were 
to determine whether the effect of an antenatal maternal dietary and lifestyle intervention among 
women who are overweight or obese on newborn adiposity, was modified by paternal obesity. We 
conducted a secondary analysis of a multicenter randomised trial. Pregnant women with BMI ≥25 kg/
m2 received either Lifestyle Advice or Standard Care. Paternal anthropometric measures included 
height, weight, BMI; waist, hip, calf and mid-upper arm circumferences; biceps and calf skinfold 
thickness measurements (SFTM); and percentage body fat. Newborn anthropometric outcomes 
included length; weight; head, arm, abdominal, and chest circumferences; biceps, triceps, subscapular, 
suprailiac, thigh, and lateral abdominal wall SFTM; and percentage body fat. The effect of an antenatal 
maternal dietary and lifestyle intervention among women who were overweight or obese on neonatal 
anthropometric measures, was significantly modified by paternal BMI ≥35.0 kg/m2, with a significantly 
smaller infant triceps, suprailiac, and thigh SFTM, and percent fat mass, compared with that observed 
in offspring of lean fathers. Further research is required to determine whether our observed associations 
are causal, and whether paternal weight loss prior to conception is a potential strategy to reduce the 
intergenerational effects of obesity.
Globally 2.1 billion adults are overweight or obese1. In many developed countries, overweight and obesity has 
increased over the past three decades1, with over 70% of adult males and 60% of females having a body mass 
index (BMI) above 25.0 kg/m2 1. Obesity contributes significantly to overall burden of disease2, being associated 
with increased risks of cardiovascular disease, type-2 diabetes and many malignancies3, contributing indirectly to 
more than 3.4 million deaths annually4.
Overweight and obesity during pregnancy represents a significant health burden, with almost 50% of women 
having a BMI above 25 kg/m2 on entering pregnancy5. Adverse effects of high maternal BMI on maternal preg-
nancy outcomes are well documented, the risks increasing as BMI increases6, 7. Furthermore, maternal obesity is 
associated with an increased risk of high infant birth weight, nursery admission, preterm birth, congenital anom-
alies, and both jaundice and hypoglycaemia7, with both high maternal BMI and gestational weight gain significant 
predictors of offspring obesity8. In an attempt to improve maternal and infant outcomes, interest has focused on 
interventions in the antenatal period to limit gestational weight gain, with systematic reviews and meta-analyses 
of randomized trials identifying only a modest effect on maternal weight change9, 10.
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Paternal contributions to fetal growth, infant birth weight and body composition are less well described. 
Paternal height has been consistently correlated with birth weight and measures of skeletal growth, primarily 
birth length11–15. While some report positive associations between paternal weight and infant birth weight16, 17, 
this is not universal14. Furthermore, while some have identified associations between paternal BMI and infant 
birth weight16, 18, 19, others have not11, 13, 20. These studies have limitations. Most have not evaluated the contribu-
tion of paternal BMI to newborn anthropometric measures of adiposity, have involved relatively lean individuals, 
and have not adequately controlled for maternal factors contributing to fetal growth, or have relied upon maternal 
reporting of paternal weight and height.
The impact of paternal obesity on the efficacy of pregnancy interventions to limit gestational weight gain, 
particularly among overweight or obese women, has not been examined. We have reported the primary find-
ings of the LIMIT randomised trial evaluating provision of antenatal dietary and lifestyle advice to women who 
were overweight or obese, indicating an 18% relative risk reduction in infant birth weight above 4 kg21, following 
improvements in maternal diet and physical activity22. The planned secondary study reported here, evaluated 
whether the effect of a randomised antenatal maternal dietary and lifestyle intervention among women who are 
overweight or obese on newborn adiposity measures, was modified by paternal BMI.
Results
We randomized 2,212 women, (1,108 Lifestyle Advice; 1,104 Standard Care). There were 2,142 live-born infants 
(1,075 Lifestyle Advice; 1,067 Standard Care), with detailed anthropometric measurements for 913 fathers and 
infants (442 Lifestyle Advice; 471 Standard Care) (Fig. 1). Baseline characteristics of mothers of these infants were 
similar between treatment groups (Table 1), and similar to the full randomised groups21. Paternal (Table 2) and 
neonatal23 anthropometric measurements were also similar between treatment groups. There was a statistically 
significant correlation between maternal and paternal BMI (Pearson correlation coefficient 0.22, p < 0.001); a 
Figure 1. Flow of participants through the trial.
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higher proportion of fathers were in the obese category for the highest maternal BMI groups compared to the 
lowest; however more than 50% of fathers had BMI <30 in every maternal BMI category.
Modification of the antenatal dietary and lifestyle intervention on neonatal anthropometry 
by paternal BMI. Increasing paternal BMI significantly modified the effect of the antenatal intervention on 
infant triceps (p = 0.03) and suprailiac (p = 0.02) skinfold thickness measurement (SFTM), with some evidence 
to suggest paternal BMI was an effect modifier for thigh SFTM (p = 0.06) (Table 3). Specifically, in infants born to 
a father with BMI ≥35.0 kg/m2 the antenatal intervention was associated with smaller average triceps SFTM by 
0.89 mm while no significant effect of the intervention was seen for infants born to fathers with BMI <25.0 kg/m2, 
or 30.0–34.9 kg/m2. Paternal BMI ≥35.0 kg/m2 modified the effect of the intervention for average infant suprail-
iac SFTM, which was smaller by 1.87 mm in the intervention group, in contrast to infants of fathers with BMI 
<25.0 kg/m2, 25.0–29.9 kg/m2 and 30.0–34.9 kg/m2 respectively.
Paternal BMI ≥35.0 kg/m2 also positively modified the effect of the antenatal intervention on infant 
thigh SFTM, being associated with smaller average thigh SFTM of 1.01 mm, when compared with the small, 
Characteristic
Lifestyle Advice 
(N = 442)
Standard Care 
(N = 471)
Maternal Age (Years)* 29.5 (5.7) 29.6 (5.4)
Gestational Age at Entry 
(Weeks)+ 14.0 (11.9–16.6) 14.1 (11.7–16.7)
Body Mass Index (kg/m2)+ 31.1 (27.9–36.2) 31.3 (27.6–36.3)
Body Mass Index Category#
 BMI 25.0–29.9 187 (42.3) 190 (40.3)
 BMI 30.0–34.9 112 (25.3) 135 (28.7)
 BMI 35.0–39.9 90 (20.4) 79 (16.8)
 BMI >=40.0 53 (12.0) 67 (14.2)
Public Patient# 429 (97.1) 461 (97.9)
Caucasian# 412 (93.2) 431 (91.5)
Smoker# 41 (9.3) 48 (10.2)
Nulliparous# 210 (47.5) 231 (49.0)
Index of Socio-economic Disadvantage^
 Quintile 1 (Most 
Disadvantaged) 123 (27.8) 130 (27.6)
 Quintile 2 115 (26.0) 135 (28.7)
 Quintile 3 69 (15.6) 67 (14.2)
 Quintile 4 64 (14.5) 74 (15.7)
 Quintile 5 (Least 
Disadvantaged) 71 (16.1) 65 (13.8)
Table 1. Maternal baseline characteristics by randomised group. *Mean and standard deviation. +Median and 
interquartile range. #Number and %. ^Socioeconomic index as measured by SEIFA.
Characteristic
Lifestyle Advice 
(N = 442)
Standard Care 
(N = 471)
Weight (kg)* 91.9 (18.4) 91.9 (18.7)
Height (cm)* 179.0 (6.8) 179.1 (7.5)
Body Mass Index (kg/
m2)* 28.7 (5.6) 28.6 (5.4)
Body Mass Index Category#
 Missing 8 (1.8) 10 (2.1)
 BMI <25 110 (24.9) 110 (23.4)
 BMI 25-<30 183 (41.4) 193 (41.0)
 BMI 30-<35 89 (20.1) 110 (23.4)
 BMI >=35 52 (11.8) 48 (10.2)
Age (years)*,^ 32.58 (6.34) 32.54 (6.35)
Calculated Fat Mass 
(kg)+ 17.2 (11.3–24.8) 17.7 (11.8–24.8)
Calculated Percent Body 
Fat+ 19.4 (14.3–25.0) 19.3 (14.4–25.2)
Table 2. Paternal anthropometric characteristics by maternal randomised treatment group. *Mean and 
standard deviation. +Median and interquartile range. #Number and %. ^Based on a subset of 197 fathers (101 
Lifestyle Advice, 96 Standard Care) for whom information on date of birth was available.
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Infant Outcome
Paternal BMI 
Category
Lifestyle Advice 
(N = 442)
Standard Care 
(N = 471)
Adjusted Treatment 
Effect (95% CI)
Adjusted 
P-value
Adjusted 
Interaction 
P-value
Birth Weight (g)
BMI <25 3470.45 (473.04) 3492.44 (547.94) −26.19 (−167.95, 115.57) 0.712
0.93
BMI 25–<30 3555.73 (466.05) 3520.90 (547.15) 22.06 (−86.62, 130.74) 0.69
BMI 30–<35 3515.25 (546.53) 3512.65 (708.76) −20.99 (−169.61, 127.63) 0.78
BMI >=35 3538.54 (491.83) 3560.77 (509.84) −34.80 (−244.12, 174.52) 0.75
Birth Length (cm)
BMI <25 49.94 (2.14) 50.00 (2.37) −0.08 (−0.71, 0.55) 0.8
0.64
BMI 25–<30 50.18 (1.90) 50.09 (2.31) 0.06 (−0.42, 0.54) 0.79
BMI 30–<35 50.01 (2.31) 49.59 (3.24) 0.38 (−0.28, 1.03) 0.26
BMI >=35 49.64 (2.30) 49.84 (2.13) −0.31 (−1.24, 0.62) 0.51
Head 
Circumference 
(cm)
BMI <25 34.94 (1.29) 34.98 (1.70) −0.10 (−0.52, 0.33) 0.66
0.41
BMI 25–<30 34.91 (1.41) 34.88 (1.64) 0.03 (−0.29, 0.36) 0.84
BMI 30–<35 34.92 (1.42) 34.63 (2.01) 0.24 (−0.21, 0.68) 0.29
BMI >=35 34.66 (1.78) 35.06 (1.71) −0.40 (−1.04, 0.23) 0.21
Chest 
Circumference 
(cm)
BMI <25 34.23 (1.78) 34.45 (1.91) −0.25 (−0.93, 0.44) 0.48
0.4
BMI 25–<30 34.39 (1.79) 34.09 (2.02) 0.35 (−0.18, 0.89) 0.2
BMI 30–<35 34.27 (2.12) 34.45 (2.12) −0.32 (−1.04, 0.40) 0.39
BMI >=35 33.92 (1.87) 33.86 (2.35) −0.15 (−1.11, 0.82) 0.76
Mid Upper Arm 
Circumference 
(cm)
BMI <25 11.29 (0.89) 11.19 (1.18) 0.02 (−0.34, 0.38) 0.91
0.82
BMI 25–<30 11.30 (1.01) 11.18 (1.11) 0.10 (−0.18, 0.38) 0.49
BMI 30–<35 11.22 (0.90) 11.12 (0.98) 0.03 (−0.35, 0.41) 0.88
BMI >=35 11.23 (1.05) 10.90 (1.08) 0.30 (−0.21, 0.81) 0.25
Abdominal 
Circumference 
(cm)
BMI <25 32.95 (2.10) 32.82 (2.35) −0.02 (−0.79, 0.75) 0.95
0.18
BMI 25–<30 32.99 (2.13) 32.59 (2.34) 0.40 (−0.20, 1.00) 0.2
BMI 30–<35 32.72 (2.23) 33.15 (2.24) −0.67 (−1.48, 0.13) 0.1
BMI >=35 32.69 (1.96) 32.26 (2.52) 0.40 (−0.68, 1.49) 0.47
Biceps SFTM 
(mm)
BMI <25 4.23 (0.94) 4.13 (1.36) 0.07 (−0.34, 0.48) 0.74
0.81
BMI 25–<30 4.60 (1.33) 4.41 (1.15) 0.16 (−0.16, 0.49) 0.32
BMI 30–<35 4.38 (1.26) 4.19 (1.02) 0.19 (−0.24, 0.63) 0.39
BMI >=35 4.20 (1.07) 4.35 (1.03) −0.13 (−0.72, 0.45) 0.65
Triceps SFTM 
(mm)
BMI <25 5.33 (1.27) 5.37 (1.57) −0.13 (−0.61, 0.36) 0.61
0.03
BMI 25–<30 5.61 (1.30) 5.32 (1.44) 0.27 (−0.11, 0.65) 0.16
BMI 30–<35 5.25 (1.48) 5.33 (1.29) −0.14 (−0.64, 0.37) 0.59
BMI >=35 5.03 (1.12) 5.94 (1.50) −0.89 (−1.57, −0.22) 0.01
Suprailiac SFTM 
(mm)
BMI <25 5.57 (1.76) 5.55 (1.67) −0.09 (−0.75, 0.57) 0.79
0.002
BMI 25–<30 5.94 (1.67) 5.73 (1.87) 0.21 (−0.30, 0.72) 0.42
BMI 30–<35 5.72 (2.20) 5.77 (2.11) −0.08 (−0.77, 0.62) 0.83
BMI >=35 5.12 (1.52) 7.03 (2.20) −1.87 (−2.81, −0.93) 0.0001
Subscapular 
SFTM (mm)
BMI <25 5.25 (1.17) 5.05 (1.13) 0.14 (–0.32, 0.60) 0.55
0.64
BMI 25–<30 5.13 (1.42) 5.08 (1.27) 0.06 (−0.30, 0.42) 0.75
BMI 30–<35 5.02 (1.49) 5.10 (1.16) −0.14 (−0.62, 0.34) 0.56
BMI >=35 5.12 (1.19) 5.44 (1.64) −0.31 (−0.96, 0.33) 0.34
Lateral 
Abdominal SFTM 
(mm)
BMI <25 3.72 (1.05) 3.65 (1.03) 0.06 (−0.32, 0.43) 0.77
0.55
BMI 25–<30 4.02 (1.21) 3.83 (1.04) 0.19 (−0.11, 0.49) 0.21
BMI 30–<35 3.84 (1.07) 3.66 (1.01) 0.13 (−0.27, 0.52) 0.53
BMI >=35 3.63 (0.92) 3.93 (0.88) −0.26 (−0.79, 0.28) 0.35
Thigh SFTM 
(mm)
BMI <25 6.68 (1.79) 6.54 (1.81) 0.06 (−0.60, 0.71) 0.86
0.06
BMI 25–<30 7.40 (1.92) 6.99 (1.89) 0.45 (−0.06, 0.95) 0.08
BMI 30–<35 6.97 (2.21) 6.92 (1.72) −0.06 (−0.74, 0.62) 0.86
BMI >=35 6.61 (1.65) 7.67 (2.14) −1.01 (−1.92, −0.09) 0.03
Calculated Fat 
Mass (g)
BMI <25 519.15 (161.25) 514.15 (169.81) −0.37 (−67.79, 67.05) 0.99
0.12
BMI 25–<30 546.39 (169.81) 508.34 (196.11) 37.26 (−14.61, 89.13) 0.16
BMI 30–<35 520.08 (239.72) 528.87 (197.73) −20.21 (−89.36, 48.94) 0.57
BMI >=35 478.74 (137.34) 555.62 (200.03) −89.49 (−182.90, 3.93) 0.06
Calculated Fat 
Free Mass (g)*
BMI <25 3058.33 (282.29) 3062.06 (357.21) −7.80 (−131.49, 115.90) 0.9
0.88
BMI 25–<30 3069.61 (305.55) 3009.87 (360.21) 52.80 (−42.36, 147.97) 0.28
BMI 30–<35 3066.72 (380.31) 3027.67 (389.34) 5.19 (−121.68, 132.05) 0.94
BMI >=35 2986.76 (375.95) 2910.80 (380.12) 28.40 (−142.99, 199.78) 0.75
Continued
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non-significant treatment effects seen among infants of fathers with BMI <25.0 kg/m2, 25.0–29.9 kg/m2, and 
30.0–34.9 kg/m2 respectively. This finding should be interpreted with caution however, as the treatment group by 
paternal BMI category interaction test did not reach statistical significance (p = 0.06).
Paternal BMI ≥35 kg/m2 also positively modified infant percentage body fat in response to the intervention 
(p = 0.02; Table 3). Treatment effects were again seen for infants of fathers in the highest BMI category only, where 
the intervention was associated with significantly smaller percent body fat by 2.15%.
Increasing paternal BMI did not significantly modify the effect of the antenatal intervention on mean infant 
birth weight, birth length, or body circumferences (Table 3).
In the Standard Care group only, paternal BMI category was associated with significant differences in mean 
suprailiac SFTM (p = 0.005) and thigh SFTM (p = 0.04), and there was some evidence of a difference in mean per-
cent body fat (p = 0.06), but there were no other statistically significant differences between subgroups (Table 4).
Discussion
Our findings identify an association between high paternal BMI and some measures of newborn adiposity. 
Specifically, the effect of the antenatal intervention in terms of smaller anthropometric measures of adiposity 
was significantly enhanced in infants whose fathers had a BMI ≥35.0 kg/m2, as demonstrated by smaller average 
infant triceps, suprailiac, and thigh SFTM, and infant percent fat mass in the intervention group.
Strengths of our study include its prospective, randomised nature and rigorous methodology, utilising stand-
ardised and well-accepted research standard anthropometric measures, adhering to defined protocols23, 24. In 
analysing the effect of paternal BMI on infant adiposity, we have controlled for maternal BMI, gestational weight 
gain, and other pregnancy factors influencing fetal growth and therefore birth weight. Importantly, our study 
allows us to address the potential contribution of paternal obesity to a range of infant anthropometric measures 
that include adiposity, which has not been possible to date, as previously reported cohorts have utilised relatively 
lean populations, with few participants at the upper extremes of the BMI spectrum11–16, 25.
Limitations include lack of a gold standard measure of paternal and infant adiposity, however the use of 
dual x-ray absorptiometry or air displacement plethysmography was prohibitive in the context of this large ran-
domised trial. We have previously reported good reproducibility with infant skin fold measurements23. Timing 
of partner measurements would ideally have been at the woman’s first pregnancy visit, however women were not 
enrolled until several weeks after this visit, and paternal measures were taken on average at about 90 days after 
randomisation. Average young adult male weight change in one year is 0.6 kg26, and over the five-month time 
frame in which paternal measurements were obtained were considered unlikely to change. We also conducted 
further analyses (not reported) to check for any effect of the intervention on paternal measures; these found no 
differences between the Lifestyle Advice and Standard Care groups.
The effects of paternal height on newborn length and measures of skeletal growth11, 25 and weight11–16, have 
been reasonably well described and appear to be independent of both maternal height and weight. There are well 
reported associations between paternal height and both newborn length or measures of skeletal growth11, 25, and 
weight11–16, across varying populations world-wide, and over different time periods. Catalano and colleagues27 
reported a weak positive association between paternal height and estimated infant fat free mass, the outcome 
more strongly associated with infant sex, gestational age at birth, maternal gestational weight gain, and maternal 
BMI prior to conception.
The contribution of paternal weight and BMI to infant anthropometric measures has been less clearly estab-
lished to date. While the majority of studies have failed to identify associations between either paternal weight or 
BMI and infant birth weight11–15, Mikulandra and colleagues16 report on almost 1,600 newborns from Croatia, 
identifying a significant positive association between increasing paternal weight and BMI, and increasing infant 
birth weight. These findings are consistent with those of Chen and colleagues in an Asian population18, and 
Klebanoff and colleagues, who utilized Danish population linked data from women birthing between 1974 and 
198919. In contrast, other studies conducted in predominantly Caucasian populations11, 13, 20 have not identified 
an association between increasing paternal BMI and infant birth weight. Most of these studies11, 13, 16, 18–20 have 
focused on infant birth weight, rather than investigating more direct measures of infant adiposity as we have.
The contribution of paternal obesity to human pregnancy outcomes has been previously poorly documented. 
The association between paternal BMI and infant adiposity described here may reflect paternal genetic influences, 
Infant Outcome
Paternal BMI 
Category
Lifestyle Advice 
(N = 442)
Standard Care 
(N = 471)
Adjusted Treatment 
Effect (95% CI)
Adjusted 
P-value
Adjusted 
Interaction 
P-value
Calculated 
Percent Body Fat
BMI <25 14.31 (3.39) 14.09 (3.29) 0.12 (−1.13, 1.38) 0.85
0.02
BMI 25–<30 14.85 (3.28) 14.03 (3.61) 0.84 (−0.12, 1.81) 0.09
BMI 30–<35 13.93 (4.28) 14.50 (3.27) −0.70 (−1.99, 0.59) 0.29
BMI >=35 13.63 (2.78) 15.63 (3.77) −2.15 (−3.89, −0.40) 0.02
Table 3. Treatment effect modification of infant morphology, according to paternal body mass index category. 
Values are mean (SD) and treatment effects are differences in means. Where the interaction p-value is not 
significant, treatment group comparisons within subgroups should be interpreted with caution. Results have 
been adjusted for centre, maternal parity, maternal BMI, maternal age, socioeconomic status and maternal 
smoking status. *Calculated using equation from Deierlein et al.42. Note that ‘ethnicity’ (Hispanic vs non-
Hispanic) is included in this equation but is not applicable to the LIMIT cohort (all participants are ‘non-
Hispanic’).
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or paternal influences acting through the gamete environment prior to conception, or both. Our novel findings 
indicate that paternal obesity also significantly modifies the effect of an antenatal dietary and lifestyle interven-
tion among pregnant women who are overweight or obese, on neonatal anthropometric measures of adiposity. 
One potential hypothesis to explain this observation may be that with increasing paternal BMI there is greater 
“familial” awareness of obesity, with women whose partners are of higher BMI being more supported to initiate 
changes to dietary and physical activity patterns. We investigated this possibility in a post-hoc analysis, but found 
no supporting evidence, with no substantial variation in maternal dietary and physical activity patterns across 
the paternal BMI spectrum.
There is increasing experimental evidence to support a male contribution to the development of offspring 
obesity, independent of genetics and a shared postnatal environment. Observational human literature identifies 
well recognized associations between paternal obesity, and an altered hormonal environment, impaired spermat-
ogenesis, with reduced sperm counts28, 29 and impaired DNA integrity and mitochondrial function, secondary to 
increased reactive oxygen species28. Furthermore, these obesity related effects on spermatogenesis appear revers-
ible through weight loss, either from dietary modification28, or following bariatric surgery29.
Animal based studies have identified similar reversible changes in spermatogenesis following diet-induced 
obesity in rodents30, 31, with suggestions that this impacts blastocyst function in early conception32. Furthermore, 
rodents fed a high-fat diet to induce obesity, both in the presence33 and absence34 of impaired glucose homeo-
stasis, father offspring, particularly females, who are heavier, have reduced glucose tolerance, increased insulin 
resistance, and increased adiposity33, 34. Many of these adiposity effects persist in subsequent generations35.
While there is evidence to support a role for a male contribution to the development of offspring obesity, the 
precise mechanism whereby this “transmission” occurs remains uncertain36. Hypotheses include aberrant repair of 
spermatozoa DNA damage37, epigenetic changes reflecting hypo-methylation of histone bound DNA regions33, 38, 
and changes to non-coding small RNAs, such as micro RNAs39.
Of particular interest are the mechanisms underlying the effect of paternal BMI on the efficacy of the inter-
vention in substantially ameliorating the increased infant adiposity associated with a high paternal BMI. The 
intervention, which improved maternal diet quality and physical activity22, presumably targets pathways in the 
fetus that mediate paternal genetic or preconception environmental influences on infant adiposity. These appear 
distinct from those harnessed by maternal obesity as by contrast, the intervention did not improve infant adipos-
ity associated with a high maternal BMI23. Identifying the paternal pathways contributing to excess fetal adipose 
accumulation may reveal new targets and potential interventions to limit this.
Our findings highlight the need for ongoing research within human male populations into the impact of 
obesity on pregnancy and offspring health. Further research is required to determine whether our observed asso-
ciations are causal, and, if so, whether paternal weight loss prior to conception would affect infant adiposity, as a 
potential strategy to reduce the adverse intergenerational effects of obesity.
Subjects and Methods
Study Design and Participants. The methodology40 and clinical findings have been reported21, 22, 41, 
and the trial registered on the Australian and New Zealand Clinical Trials Registry (ACTRN12607000161426). 
The LIMIT Study has been conducted in accordance with ethical and legal guidelines at the time the study was 
Infant Characteristic
Paternal BMI 
<25 (N = 110)
Paternal BMI 25-
<30 (N = 193)
Paternal BMI 30-
<35 (N = 110)
Paternal BMI 
>=35 (n = 48)
P 
value
Weight (g) 3492.44 (547.94) 3520.90 (547.15) 3512.65 (708.76) 3560.77 (509.84) 0.37
Length (cm) 50.00 (2.37) 50.09 (2.31) 49.59 (3.24) 49.84 (2.13) 0.84
Head Circumference (cm) 34.98 (1.70) 34.88 (1.64) 34.63 (2.01) 35.06 (1.71) 0.18
Chest Circumference (cm) 34.45 (1.91) 34.09 (2.02) 34.45 (2.12) 33.86 (2.35) 0.12
Mid Upper Arm 
Circumference (cm) 11.19 (1.18) 11.18 (1.11) 11.12 (0.98) 10.90 (1.08) 0.83
Abdominal 
Circumference (cm) 32.82 (2.35) 32.59 (2.34) 33.15 (2.24) 32.26 (2.52) 0.13
Biceps SFTM (mm) 4.13 (1.36) 4.41 (1.15) 4.19 (1.02) 4.35 (1.03) 0.45
Triceps SFTM (mm) 5.37 (1.57) 5.32 (1.44) 5.33 (1.29) 5.94 (1.50) 0.07
Suprailiac SFTM (mm) 5.55 (1.67) 5.73 (1.87) 5.77 (2.11) 7.03 (2.20) 0.005
Subscapular SFTM (mm) 5.05 (1.13) 5.08 (1.27) 5.10 (1.16) 5.44 (1.64) 0.15
Lateral Abdominal SFTM 
(mm) 3.65 (1.03) 3.83 (1.04) 3.66 (1.01) 3.93 (0.88) 0.51
Thigh SFTM (mm) 6.54 (1.81) 6.99 (1.89) 6.92 (1.72) 7.67 (2.14) 0.04
Fat Mass (g) 514.15 (169.81) 508.34 (196.11) 528.87 (197.73) 555.62 (200.03) 0.22
Fat Free Mass (g) 3062.06 (357.21) 3009.87 (360.21) 3027.67 (389.34) 2910.80 (380.12) 0.24
Percent Body Fat 14.09 (3.29) 14.03 (3.61) 14.50 (3.27) 15.63 (3.77) 0.06
Table 4. Associations between infant morphology and paternal body mass index category from participants in 
the Standard Care Group. Values are mean (SD). *P-value from global test for effect of paternal BMI category. 
Results have been adjusted for maternal weight, height, BMI category, gestational weight gain, gestational 
diabetes, smoking status, socio-economic status, gestational age at birth and infant sex.
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undertaken. Protocols used in this study were approved by the Women’s and Children’s Local Health Network 
Human Research and Ethics Committee at the Women’s and Children’s Hospital, the Central Northern Adelaide 
Health Service Ethics of Human Research Committee (Lyell McEwin Hospital) and the Flinders Clinical Research 
Ethics Committee (Flinders Medical Centre). Study methods complied with the Australian National Health and 
Medical Research Council’s National Statement on Ethical Conduct in Human Research (2007) - Updated May 
2015 (https://www.nhmrc.gov.au/guidelines-publications/e72). Women with a singleton pregnancy between 
10+0–20+0 weeks gestation, with BMI ≥25 kg/m2 were eligible.
Intervention. At the first antenatal appointment, women had their height and weight measured, and BMI 
calculated. Eligible women were presented with written information prior to providing consent. The central ran-
domisation service utilised a computer-generated schedule with balanced variable blocks, and stratification for 
parity (0 versus 1/more), BMI at booking (25–29.9 kg/m2 versus ≥30 kg/m2), and collaborating centre. Women 
were randomised to either ‘Lifestyle Advice’ or ‘Standard Care’.
Lifestyle Advice Group. Women participated in a comprehensive dietary and lifestyle intervention over preg-
nancy, delivered by a research dietician and research assistants21, 22.
Standard Care Group. Women continued their care according to local hospital guidelines, which did not include 
dietary, exercise, or gestational weight gain advice.
Outcome Variables. Maternal BMI and gestational weight gain. At antenatal booking, women were cate-
gorised as overweight (BMI 25.0–29.9 kg/m2) or obese (BMI ≥30 kg/m2). Gestational weight gain was the differ-
ence in weight between 36 weeks gestation (or nearest to birth) and trial entry.
Paternal BMI and Anthropometry. Following informed consent, trained research assistants obtained detailed 
anthropometric measurements from the infant’s father during his partner’s pregnancy. Weight and height were 
measured to the nearest 0.1 kg and 0.1 cm respectively, in light clothing without shoes. BMI was categorised as 
normal (BMI <25 kg/m2), overweight (BMI 25.0–29.9 kg/m2), obese (BMI 30.0–34.9 kg/m2), or morbidly obese 
(BMI ≥35.0 kg/m2).
Waist, hip, calf, and mid-upper arm circumferences were obtained, and Harpenden skinfold callipers used to 
measure biceps and calf skinfold thicknesses. The following formula, derived from a demographically matched 
sample within an extensive database of complete anthropometric measurements, was used as a surrogate estimate 
of percentage body fat, total fat mass, and total non-fat mass (personal communication, Professor Timothy Olds, 
17/10/12).
. . . . .
. .
= + − + −
+ +
BF 4 3 0 099 Mass 0 099 Ht 0 564 BicepsSF 0 076 ArmG
0 539 CalfSF 0 166 WaistG
where BF = Body fat (%), Mass = Body Weight (kg), Ht = Height (cm), BicepsSF = Biceps skin fold thickness 
(mm), ArmG = Arm girth (cm), CalfSF = Calf skinfold thickness (mm), and WaistG = Waist Girth (cm).
Newborn Anthropometry. Prior to discharge from hospital, a trained research assistant obtained newborn 
anthropometric measures on healthy newborn infants on the postnatal ward, including birth weight, length, body 
circumference (head, arm, chest, and abdomen) and skinfold thickness measurements (SFTM) (biceps, triceps, 
subscapular, supra-iliac, thigh and lateral abdominal)23.
Infant gender, age in days and the sum of triceps, subscapular and thigh SFTM were used to calculate fat 
mass42. Percent body fat was calculated (fat mass/body weight at birth) × 100.
Statistical Analyses. To evaluate whether the effect of a randomised antenatal maternal dietary and life-
style intervention among women who are overweight or obese on newborn adiposity measures, was modified 
by paternal BMI, we conducted intention to treat analyses, according to the woman’s allocated treatment group 
at randomisation. Live born infants were included if their mother consented to anthropometric measurements 
being taken, and one or more paternal anthropometric measurements were available. Linear regression models 
were used to test whether the effect of treatment was modified by paternal BMI category and other measures of 
paternal adiposity, by including an intervention-by-paternal BMI category term in the model. Post-hoc tests were 
performed to estimate the effect of treatment group within each paternal BMI category and results are presented 
as differences in means with 95% CI. Adjustment was made for centre, parity, maternal BMI category, maternal 
age, socio-economic status and maternal smoking status.
To evaluate whether there was an association between paternal BMI and infant adiposity, analyses were con-
ducted using data from the Standard Care group only. Linear regression models were used to test whether there 
was a difference in infant outcome by paternal BMI category (categories being used rather than continuous BMI 
to allow for nonlinearity of association and to aid interpretability). Separate estimates of difference in means were 
derived for each paternal BMI category. Analyses were adjusted for maternal BMI, gestational weight gain, gesta-
tional diabetes, socioeconomic status, gestational age at delivery, and maternal smoking.
Statistical significance was assessed at the 2-sided p < 0.05 level. As these are secondary analyses (with the 
findings considered exploratory), no adjustment for multiple comparisons has been made43, 44. All analyses were 
performed using SAS v9.3 (Cary, NC, USA).
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